Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02933476 · ClinicalTrials.gov registry record · NA
Vibrotactile Stimulation in Parkinson's Disease
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02933476: Completed NA study, sponsored by Stanford University.
NCT02933476 is a NA study that has completed, run by Stanford University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02933476, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the possibility of a new, non-invasive, non-drug treatment for Parkinson's disease. The treatment involves gentle vibratory stimulation delivered to the fingertips (called 'vibrotactile stimulation'). Along with the treatment, participants will also undergo kinematic testing.
Primary Outcome
Questionnaire asks patients to record any adverse effects they experienced.
Interventions
- DEVICE Vibrotactile Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT02933476 record still lists
NCT02933476 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Vibrotactile Stimulation is the first listed.
NCT02933476 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02933476 about?
NCT02933476 is a clinical study titled "Vibrotactile Stimulation in Parkinson's Disease". The purpose of this study is to examine the possibility of a new, non-invasive, non-drug treatment for Parkinson's disease. The treatment involves gentle vibratory stimulation delivered to the fingertips (called 'vibrotactile stimulation'). Along with the treatment, participants will also undergo ki...
What is the current status of trial NCT02933476?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2016-05. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02933476?
The interventions under investigation include: Vibrotactile Stimulation (DEVICE).
Who is sponsoring clinical trial NCT02933476?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02933476's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia